Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase

[1]  M. Stasia,et al.  Genetics and immunopathology of chronic granulomatous disease , 2008, Seminars in Immunopathology.

[2]  T. S. Wilkinson,et al.  Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. , 2008, American journal of respiratory and critical care medicine.

[3]  A. Vliet.  NADPH oxidases in lung biology and pathology: host defense enzymes, and more. , 2008 .

[4]  D. Roos,et al.  Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. , 2008, The Journal of allergy and clinical immunology.

[5]  L. Notarangelo,et al.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. , 2008, Clinical immunology.

[6]  A. Fischer,et al.  Efficiency of hydroxychloroquine in the treatment of granulomatous complications in chronic granulomatous disease. , 2008, European journal of gastroenterology & hepatology.

[7]  U. Grohmann,et al.  Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease , 2008, Nature.

[8]  P. Emery,et al.  TRPC channel activation by extracellular thioredoxin , 2008, Nature.

[9]  K. Krause,et al.  Branched fungal β‐glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase‐deficient mice , 2007, The Journal of pathology.

[10]  R. Holmdahl,et al.  Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. , 2007, The Journal of clinical investigation.

[11]  L. Alfredsson,et al.  A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity , 2007, Arthritis research & therapy.

[12]  J. Lambeth.  Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. , 2007, Free radical biology & medicine.

[13]  R. Holmdahl,et al.  Lack of Reactive Oxygen Species Breaks T Cell Tolerance to Collagen Type II and Allows Development of Arthritis in Mice1 , 2007, The Journal of Immunology.

[14]  B. Migeon.  Why females are mosaics, X-chromosome inactivation, and sex differences in disease. , 2007, Gender medicine.

[15]  D. Zillikens,et al.  NADPH oxidase is required for neutrophil‐dependent autoantibody‐induced tissue damage , 2007, The Journal of pathology.

[16]  D. Goldblatt,et al.  Cutaneous and other lupus‐like symptoms in carriers of X‐linked chronic granulomatous disease: incidence and autoimmune serology , 2007, Clinical and experimental immunology.

[17]  Karl-Heinz Krause,et al.  Aging: A revisited theory based on free radicals generated by NOX family NADPH oxidases , 2007, Experimental Gerontology.

[18]  J. Wallace,et al.  Resolution of in flammation: state of the art, definitions and terms , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  K. Krause,et al.  A key role for the microglial NADPH oxidase in APP-dependent killing of neurons , 2006, Neurobiology of Aging.

[20]  T. Hussell,et al.  In the Absence of Reactive Oxygen Species, T Cells Default to a Th1 Phenotype and Mediate Protection against Pulmonary Cryptococcus neoformans Infection , 2006, The Journal of Immunology.

[21]  F. Abbasakoor,et al.  Gastrointestinal manifestations of chronic granulomatous disease , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[23]  R. Holmdahl,et al.  A New Arthritis Therapy with Oxidative Burst Inducers , 2006, PLoS medicine.

[24]  R. Holmdahl,et al.  T cell surface redox levels determine T cell reactivity and arthritis susceptibility , 2006, Proceedings of the National Academy of Sciences.

[25]  S. Przedborski,et al.  The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice , 2006, Proceedings of the National Academy of Sciences.

[26]  P. Hawkins,et al.  Neutrophils from p40phox−/− mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing , 2006, The Journal of experimental medicine.

[27]  E. Klann,et al.  Synaptic Plasticity Deficits and Mild Memory Impairments in Mouse Models of Chronic Granulomatous Disease , 2006, Molecular and Cellular Biology.

[28]  T. Hussell,et al.  An absence of reactive oxygen species improves the resolution of lung influenza infection , 2006, European journal of immunology.

[29]  H. Koyama,et al.  Earlier onset of neutrophil-mediated inflammation in the ultraviolet-exposed skin of mice deficient in myeloperoxidase and NADPH oxidase , 2006, Inflammation Research.

[30]  S. Ohga,et al.  A Case of Chronic Recurrent Uveitis Associated with Chronic Granulomatous Disease , 2006, Japanese Journal of Ophthalmology.

[31]  J. Garssen,et al.  Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. , 2006, European journal of pharmacology.

[32]  A. Sanford,et al.  Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus. , 2006, Rheumatology.

[33]  N. Sebire,et al.  Histopathological features of chronic granulomatous disease (CGD) in childhood , 2005, Histopathology.

[34]  L. Fiette,et al.  Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. , 2005, Blood.

[35]  Yutaka Sato,et al.  Imaging of chronic granulomatous disease in children. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[36]  R. Dringen.  Oxidative and antioxidative potential of brain microglial cells. , 2005, Antioxidants & redox signaling.

[37]  Mark H. Moss,et al.  Health-Related Quality of Life of Children With Primary Immunodeficiency Disease: A Comparison Study , 2005, Pediatrics.

[38]  F. Breedveld,et al.  Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[39]  K. Nabbe,et al.  NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-γ-stimulated immune complex arthritis , 2005, Arthritis research & therapy.

[40]  J. Keenan,et al.  NADPH oxidase involvement in the pathology of Helicobacter pylori infection. , 2005, Free radical biology & medicine.

[41]  Gang-yi Wu,et al.  Synaptic localization of a functional NADPH oxidase in the mouse hippocampus , 2005, Molecular and Cellular Neuroscience.

[42]  M. Glogauer,et al.  Innate immunity and arthritis: neutrophil Rac and toll-like receptor 4 expression define outcomes in infection-triggered arthritis. , 2005, Arthritis and rheumatism.

[43]  W. Alvord,et al.  Inhibition of Human Neutrophil IL-8 Production by Hydrogen Peroxide and Dysregulation in Chronic Granulomatous Disease1 , 2005, The Journal of Immunology.

[44]  C. Hitchon,et al.  Oxidation in rheumatoid arthritis , 2004, Arthritis research & therapy.

[45]  R. Holmdahl,et al.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Francis,et al.  Rac2 is critical for neutrophil primary granule exocytosis. , 2004, Blood.

[47]  A. Campa,et al.  Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. , 2004, Immunology letters.

[48]  J. T. Miller,et al.  Cognitive function in patients with chronic granulomatous disease: a preliminary report. , 2004, Psychosomatics.

[49]  M. Podestá,et al.  Recurrent eosinophilic cystitis in a child with chronic granulomatous disease. , 2004, Journal of pediatric hematology/oncology.

[50]  Adeline R. Whitney,et al.  Gene Expression Profiling Provides Insight into the Pathophysiology of Chronic Granulomatous Disease1 , 2004, The Journal of Immunology.

[51]  L. Joosten,et al.  Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. , 2003, The American journal of pathology.

[52]  K. Krause,et al.  A Role for NOX NADPH Oxidases in Alzheimer's Disease and Other Types of Dementia? , 2003, IUBMB life.

[53]  R. Redline,et al.  Severe inflammation and reduced bacteria load in murine helicobacter infection caused by lack of phagocyte oxidase activity. , 2003, The Journal of infectious diseases.

[54]  N. Klein,et al.  The Nature of Colitis in Chronic Granulomatous Disease , 2003, Journal of pediatric gastroenterology and nutrition.

[55]  D. Goldblatt,et al.  Diminished production of anti‐inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD) , 2003, Journal of leukocyte biology.

[56]  K. Német,et al.  Calcium signalling is altered in myeloid cells with a deficiency in NADPH oxidase activity , 2003, Clinical and experimental immunology.

[57]  M. Zahalka,et al.  Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. , 2003, Arthritis and rheumatism.

[58]  R. Winn,et al.  Femoral Osteomyelitis Due to Aspergillus nidulans in a Patient with Chronic Granulomatous Disease , 2003, Infection.

[59]  K. Hadjigogos.  The role of free radicals in the pathogenesis of rheumatoid arthritis. , 2003, Panminerva medica.

[60]  M. Netea,et al.  Cytokine Release in Healthy Donors and Patients with Chronic Granulomatous Disease upon Stimulation with Aspergillus fumigatus , 2003, Scandinavian journal of infectious diseases.

[61]  O. Meyer,et al.  NADPH Oxidase Priming and p47phox Phosphorylation in Neutrophils from Synovial Fluid of Patients with Rheumatoid Arthritis and Spondylarthropathy , 2002, Inflammation.

[62]  M. Dinauer,et al.  Chemoattractant-Stimulated Rac Activation in Wild-Type and Rac2-Deficient Murine Neutrophils: Preferential Activation of Rac2 and Rac2 Gene Dosage Effect on Neutrophil Functions1 , 2002, The Journal of Immunology.

[63]  D. Parham,et al.  Extensive inflammatory eosinophilic bladder tumors in children: experience with three cases. , 2002, Southern medical journal.

[64]  S. Bingel.  Pathology of a mouse model of x-linked chronic granulomatous disease. , 2002, Contemporary topics in laboratory animal science.

[65]  S. Taniuchi,et al.  Role of reactive oxygen species in neutrophil apoptosis following ingestion of heat‐killed Staphylococcus aureus , 2002, Clinical and experimental immunology.

[66]  M. Bertolotto,et al.  Differential regulation of spontaneous and immune complex‐induced neutrophil apoptosis by proinflammatory cytokines. Role of oxidants, Bax and caspase‐3 , 2002, Journal of leukocyte biology.

[67]  Daniel A. De Ugarte,et al.  Treatment of chronic wounds by local delivery of granulocyte-macrophage colony-stimulating factor in patients with neutrophil dysfunction , 2002, Pediatric Surgery International.

[68]  J. Keenan,et al.  Oxidant‐mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease , 2002, Journal of leukocyte biology.

[69]  S. Holland,et al.  Role of NADPH Oxidase in the Mechanism of Lung Neutrophil Sequestration and Microvessel Injury Induced by Gram-Negative Sepsis: Studies in p47phox−/− and gp91phox−/− Mice1 , 2002, The Journal of Immunology.

[70]  M. Dinauer,et al.  Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease. , 2002, The Journal of investigative dermatology.

[71]  J. Roes,et al.  Ym1 Is a Neutrophil Granule Protein That Crystallizes in p47 phox -deficient Mice* , 2002, The Journal of Biological Chemistry.

[72]  K. Michaëlsson,et al.  Association between oxidative stress and bone mineral density. , 2001, Biochemical and biophysical research communications.

[73]  E. Ostrakhovitch,et al.  Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators. , 2001, Biochemical pharmacology.

[74]  D. Goldblatt,et al.  Colitis in chronic granulomatous disease , 2001, Archives of disease in childhood.

[75]  E. Ligeti,et al.  Chronic granulomatous disease: more than the lack of superoxide? , 2001, Journal of leukocyte biology.

[76]  M. Gahr,et al.  Increased susceptibility of a carrier of X-linked chronic granulomatous disease (CGD) to Aspergillus fumigatus infection associated with age-related skewing of lyonization , 2001, Annals of Hematology.

[77]  David A. Williams,et al.  Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. , 2000, Blood.

[78]  R. C. van der Veen,et al.  Superoxide Prevents Nitric Oxide-Mediated Suppression of Helper T Lymphocytes: Decreased Autoimmune Encephalomyelitis in Nicotinamide Adenine Dinucleotide Phosphate Oxidase Knockout Mice1 , 2000, The Journal of Immunology.

[79]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[80]  S. Holland,et al.  Genetic, biochemical, and clinical features of chronic granulomatous disease. , 2000, Medicine.

[81]  G L Johnson,et al.  Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Rupec,et al.  Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. , 2000, European journal of dermatology : EJD.

[83]  L. Zhan,et al.  P47phox ‐deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J‐m db/db and db/+ , 2000, Journal of leukocyte biology.

[84]  D. Goldblatt,et al.  Chorioretinal lesions in patients and carriers of chronic granulomatous disease. , 1999, The Journal of pediatrics.

[85]  D. Goldblatt,et al.  COLITIS IS COMMON IN CGD , 1999 .

[86]  M. Raftery,et al.  Oxidation Regulates the Inflammatory Properties of the Murine S100 Protein S100A8* , 1999, The Journal of Biological Chemistry.

[87]  H. Mitomi,et al.  Case Report: Colitis in Chronic Granulomatous Disease Resembling Crohn's Disease (Comparative Analysis of CD68-Positive Cells Between Two Disease Entities) , 1999, Digestive Diseases and Sciences.

[88]  D. Williams,et al.  Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. , 1999, Immunity.

[89]  S. Chanock,et al.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. , 1998, The Journal of clinical investigation.

[90]  Y. Pommier,et al.  Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. , 1998, The Journal of clinical investigation.

[91]  S. Orrenius,et al.  Redox Regulation of the Caspases during Apoptosis a , 1998, Annals of the New York Academy of Sciences.

[92]  J. Geffner,et al.  Modulation of human neutrophil apoptosis by immune complexes. , 1998, Journal of immunology.

[93]  E. Dauden,et al.  Lupus erythematosus‐like lesions in a carrier of X‐linked chronic granulomatous disease , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[94]  L. Barton,et al.  Gastrointestinal Complications of Chronic Granulomatous Disease: Case Report and Literature Review , 1998, Clinical pediatrics.

[95]  W. B. van den Berg,et al.  Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. , 1998, Arthritis and rheumatism.

[96]  P. Mortensen,et al.  Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor , 1998, Gut.

[97]  K. Német,et al.  Regulation of Capacitative Ca2+ Influx in Human Neutrophil Granulocytes , 1997, The Journal of Biological Chemistry.

[98]  S. Hoare,et al.  Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease , 1997, Archives of disease in childhood.

[99]  D. Speert,et al.  Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. , 1997, Journal of the American Academy of Dermatology.

[100]  T. Miyawaki,et al.  Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. , 1997, Blood.

[101]  M. Dinauer,et al.  Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to Aspergillus fumigatus , 1997, The Journal of experimental medicine.

[102]  S Askari,et al.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. , 1996, Immunity.

[103]  D. Mccluskey,et al.  Colitis complicating chronic granulomatous disease. A clinicopathological case report. , 1996, Gut.

[104]  Dirk Roos,et al.  Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease , 1996 .

[105]  P. Eggleton,et al.  Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[106]  U. Weser,et al.  Induction of arthritis in mice and rats by potassium peroxochromate and assessment of disease activity by whole blood chemiluminescence and 99mpertechnetate-imaging. , 1995, Free radical research.

[107]  S. Holland,et al.  The p47phox mouse knock-out model of chronic granulomatous disease , 1995, Journal of Experimental Medicine.

[108]  R. Miller,et al.  Lupus erythematosus-like oral mucosal and skin lesions in a carrier of chronic granulomatous disease. Chronic granulomatous disease carrier genodermatosis. , 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[109]  S. Abramson,et al.  The surgical implications of chronic granulomatous disease. , 1995, American journal of surgery.

[110]  L. Joosten,et al.  Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. , 1995, Arthritis and rheumatism.

[111]  H. Yap,et al.  Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. , 1994, Arthritis and rheumatism.

[112]  S. Douglas,et al.  Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. , 1993, The Journal of pediatrics.

[113]  P. Choyke,et al.  The urological manifestations of chronic granulomatous disease. , 1992, The Journal of urology.

[114]  E. Beutler,et al.  Studying X inactivation , 1992, The Lancet.

[115]  A. Ormerod,et al.  Discoid lupus erythematosus in an X‐linked cytochrome‐positive carrier of chronic granulomatous disease , 1992, The British journal of dermatology.

[116]  S. Bauer,et al.  Vesical manifestations of chronic granulomatous disease in children. Its relation to eosinophilic cystitis. , 1991, Urology.

[117]  W. Henderson,et al.  Oxidative degradation of rat mast-cell heparin proteoglycan. , 1990, The Biochemical journal.

[118]  R. Levinsky,et al.  Prognosis of chronic granulomatous disease. , 1990, Archives of disease in childhood.

[119]  A. Swaroop,et al.  Origin of mutations in two families with X-linked chronic granulomatous disease. , 1990, Blood.

[120]  A. Luz,et al.  Acidophilic Macrophage Pneumonia in Laboratory Mice , 1990, Veterinary pathology.

[121]  M. Zembala,et al.  Chronic granulomatous disease of childhood: Gastric manifestation and response to salazosulfapyridine therapy , 1989, European Journal of Pediatrics.

[122]  R. González,et al.  Urinary tract disorders in patients with chronic granulomatous disease. , 1989, The New England journal of medicine.

[123]  W. Nauseef,et al.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. , 1989, The New England journal of medicine.

[124]  R. Wells,et al.  Bilateral complete ureteral obstruction and renal insufficiency secondary to granulomatous disease. , 1989, The Journal of urology.

[125]  N. Sakura,et al.  Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4via NADPH oxidase‐dependent mechanism , 1989, European journal of clinical investigation.

[126]  J. Riggs,et al.  Pigmented, Lipid-Laden Histiocytes in the Central Nervous System in Chronic Granulomatous Disease of Childhood , 1989, Journal of child neurology.

[127]  D. Rotrosen,et al.  Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. , 1988, Science.

[128]  W. Nauseef,et al.  Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. , 1988, Science.

[129]  J. Falloon,et al.  Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. , 1987, The Journal of pediatrics.

[130]  A. Jesaitis,et al.  Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. , 1987, The Journal of clinical investigation.

[131]  P. Quie,et al.  Corticosteroids for chronic granulomatous disease. , 1987, The Journal of pediatrics.

[132]  P. Newburger,et al.  Neutrophil defect associated with malignant infantile osteopetrosis. , 1986, The Journal of laboratory and clinical medicine.

[133]  C. Feighery,et al.  Chronic granulomatous disease presenting as an oculomucocutaneous syndrome mimicking Behçet's syndrome. , 1986, Postgraduate medical journal.

[134]  R. Colletti,et al.  Gastric outlet obstruction in chronic granulomatous disease of childhood. , 1986, American journal of diseases of children.

[135]  J. Haines,et al.  DNA linkage analysis of X chromosome-linked chronic granulomatous disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[136]  P. Ward,et al.  Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease. , 1985, Human pathology.

[137]  R. Lutter,et al.  Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. , 1985, The Journal of pediatrics.

[138]  L. Joosten,et al.  Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. , 1985, The Journal of clinical investigation.

[139]  D. Isaacs,et al.  Chronic granulomatous disease mimicking Crohn's disease. , 1985, Journal of pediatric gastroenterology and nutrition.

[140]  W. Henderson,et al.  Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils. , 1983, The Journal of biological chemistry.

[141]  M. Mulholland,et al.  Gastrointestinal complications of chronic granulomatous disease: surgical implications. , 1983, Surgery.

[142]  R. Lindskov,et al.  Discoid lupus erythematosus and carrier status of X-linked chronic granulomatous disease. , 1983, Dermatologica.

[143]  K. Johansen,et al.  Discoid lupus erythematosus‐like lesions and stomatitis in female carriers of X‐linked chronic granulomatous disease , 1981, The British journal of dermatology.

[144]  K. Kragballe,et al.  Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease. , 1981, Clinical and experimental immunology.

[145]  R. Clark,et al.  Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. , 1979, The Journal of clinical investigation.

[146]  G. Wysocki,et al.  Oral manifestations of chronic granulomatous disease. , 1978, Oral surgery, oral medicine, and oral pathology.

[147]  E. Keystone,et al.  Zymosan—Induced Arthritis , 1977 .

[148]  G. Forbes,et al.  Genitourinary involvement in chronic granulomatous disease of childhood. , 1976, AJR. American journal of roentgenology.

[149]  J. Humbert,et al.  Gastric outlet obstruction due to X-linked chronic granulomatous disease. , 1975, Surgery.

[150]  W. Berdon,et al.  Gastric antral narrowing in chronic granulomatous disease of childhood. , 1974, Pediatrics.

[151]  M. Yogman,et al.  Letter: Intestinal granulomatosis in chronic granulomatous disease and in Crohn's disease. , 1974 .

[152]  H. Ochs,et al.  Gastrointestinal manifestations of chronic granulomatous disease. , 1973, The New England journal of medicine.

[153]  R. D. Harley,et al.  Chorioretinal lesions in familial chronic granulomatous disease of childhood. , 1972, American journal of ophthalmology.

[154]  S. Kontras,et al.  Interstitial cystitis in chronic granulomatous disease. , 1971, The Journal of urology.

[155]  S. Malawista,et al.  Chronic granulomatous disease in females. , 1970, The New England journal of medicine.

[156]  J. Soothill,et al.  Chronic Granulomatous Disease: Quantitative Clinicopathological Relationships , 1970, Archives of disease in childhood.

[157]  E. Kaplan,et al.  Defective polymorphonuclear-leukocyte function and chronic granulomatous disease in two female children. , 1968, The New England journal of medicine.

[158]  R. Good,et al.  The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood. , 1968, The Journal of clinical investigation.

[159]  R. Good,et al.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. , 1967, The Journal of clinical investigation.

[160]  J. White,et al.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. , 1967, The Journal of clinical investigation.

[161]  J. S. Campbell,et al.  CRYSTALLINE EXCREMENTS IN BRONCHITIS AND CHOLECYSTITIS OF MICE. , 1964, The American journal of pathology.

[162]  B. Landing,et al.  A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. , 1957, Pediatrics.

[163]  R. Good,et al.  A fatal granulomatosus of childhood: the clinical study of a new syndrome. , 1957, Minnesota medicine.

[164]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[165]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[166]  E. Mallon,et al.  Chronic granulomatous disease and peripheral ulcerative keratitis: a rare case of recurrent external ocular disease. , 2004, Bulletin de la Societe belge d'ophtalmologie.

[167]  F. S. Massie,et al.  Brain lesions in chronic granulomatous disease , 2004, Acta Neuropathologica.

[168]  C. Meischl,et al.  The molecular basis of chronic granulomatous disease , 2004, Springer Seminars in Immunopathology.

[169]  Jens Holmberg,et al.  Positional identification of Ncf1 as a gene that regulates arthritis severity in rats , 2003, Nature Genetics.

[170]  R. B. Johnston,et al.  Clinical aspects of chronic granulomatous disease. , 2001, Current opinion in hematology.

[171]  A. Arnaiz-Villena,et al.  Higher incidence of autoantibodies in X-linked chronic granulomatous disease carriers: random X-chromosome inactivation may be related to autoimmunity. , 1999, Autoimmunity.

[172]  M. Dinauer,et al.  Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[173]  J. Rosh,et al.  Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. , 1995, The Journal of pediatrics.

[174]  David A. Williams,et al.  Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production , 1995, Nature Genetics.

[175]  J. F. Johnson,et al.  Esophageal inflammation and stricture: complication of chronic granulomatous disease of childhood. , 1991, Radiology.

[176]  H. Grossniklaus,et al.  Chorioretinal lesions in chronic granulomatous disease of childhood. Clinicopathologic correlations. , 1988, Retina.

[177]  S. Orkin,et al.  The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex , 1987, Nature.

[178]  J. Markowitz,et al.  Progressive esophageal dysfunction in chronic granulomatous disease. , 1982, Journal of pediatric gastroenterology and nutrition.

[179]  A. Weathersby,et al.  Closed circuit tv monitor and culture chamber incubator for tissue culture studies. , 1971, Transactions of the American Microscopical Society.